Similarly, Purroy et al. [40], in an attempt to provide insight into the predictive ability of a biomarker-based approach among TIA patients, reported significantly higher copeptin levels in patients with stroke recurrence within 7 days but not within 3 months following TIA. This evidence concerns the gene AVP and transient ischemic attack.